Lv31
290 积分 2022-10-14 加入
Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy
4小时前
求助中
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled tria
6小时前
已完结
KIF18A inhibition: the next big player in the search for cancer therapeutics
3个月前
已完结
Whole-genome doubling drives oncogenic loss of chromatin segregation
3个月前
已完结
Profiling Numerical and Structural Chromosomal Instability in Different Cancer Types
3个月前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
3个月前
已完结
Defining ‘chromosomal instability’
4个月前
已完结
Targeting chromosomal instability in patients with cancer
4个月前
已完结
141 (PB129): Discovery of a novel KAT6A/B inhibitor with anti-tumor activity coupled with novel response biomarkers
4个月前
已完结
Aneuploidy as a promoter and suppressor of malignant growth
4个月前
已完结
皖公网安备34019202002308
